Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2244

TR 393 Mouse Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                          SODIUM FLUORIDE


NTP Experiment-Test: 05131-02                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/17/94
Route: DOSED WATER                                                                                                Time: 08:28:01




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  7681-49-4

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05131-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          SODIUM FLUORIDE                                      Date: 09/17/94  
Route: DOSED WATER                                                                                                Time: 08:28:01  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                         0 PPM       SPECIAL       25 PPM       100 PPM      175 PPM                     
                                                                CONTROL                                                             
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                         100           50           70           70           99                        
  Scheduled Sacrifice                                 20                        18           20           19                        
  Early Deaths                                                                                                                      
    Natural Death                                     13            7            5            7           16                        
    Moribund Sacrifice                                14            6            9            9           12                        
  Survivors                                                                                                                         
    Terminal Sacrifice                                53            8           38           32           51                        
    Natural Death                                                                             2            1                        
  Special Control                                                  29                                                               
  Animals Examined Microscopically                   100           42           62           63           99                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (99)         (42)         (60)         (60)         (99)                      
      Inflammation, Chronic Active                                  1 (2%)                                                          
   Gallbladder                                        (99)         (40)         (59)         (58)         (98)                      
      Cyst                                                                       1 (2%)                                             
      Mineralization                                   1 (1%)                                                                       
      Artery, Necrosis, Fibrinoid                                                             1 (2%)                                
   Intestine Small, Duodenum                          (100)        (42)         (60)         (58)         (98)                      
      Inflammation, Chronic Active                                                            2 (3%)       2 (2%)                   
   Intestine Small, Ileum                             (98)         (42)         (60)         (59)         (97)                      
      Lymphoid Tissue, Hyperplasia                                  1 (2%)                                                          
   Intestine Small, Jejunum                           (100)        (42)         (60)         (59)         (97)                      
      Inflammation, Chronic Active                     1 (1%)                                                                       
      Lymphoid Tissue, Hyperplasia                     3 (3%)                                                                       
   Liver                                              (100)        (42)         (60)         (60)         (99)                      
      Angiectasis                                                                             1 (2%)                                
      Basophilic Focus                                 2 (2%)       6 (14%)      1 (2%)       3 (5%)                                
      Clear Cell Focus                                 3 (3%)       2 (5%)       2 (3%)       2 (3%)       3 (3%)                   
      Eosinophilic Focus                              23 (23%)      4 (10%)     22 (37%)     11 (18%)     12 (12%)                  
      Hematopoietic Cell Proliferation                 6 (6%)       2 (5%)       3 (5%)       3 (5%)       6 (6%)                   
      Hepatodiaphragmatic Nodule                                    1 (2%)       1 (2%)                    1 (1%)                   
      Inflammation, Chronic Active                     2 (2%)                                 1 (2%)       3 (3%)                   
      Leukocytosis                                                  2 (5%)                                                          
      Mineralization                                                                          1 (2%)                                
      Necrosis, Coagulative                            7 (7%)       4 (10%)      4 (7%)       9 (15%)      3 (3%)                   
      Pigmentation, Hemosiderin                                     1 (2%)                    1 (2%)                                
      Vacuolization Cytoplasmic                        6 (6%)       5 (12%)      4 (7%)       7 (12%)      6 (6%)                   
      Artery, Necrosis, Fibrinoid                                                             1 (2%)                                
      Bile Duct, Cyst                                  1 (1%)       1 (2%)       1 (2%)                                             
   Mesentery                                          (28)         (6)          (16)         (18)         (28)                      
      Hemorrhage                                       1 (4%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05131-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          SODIUM FLUORIDE                                      Date: 09/17/94  
Route: DOSED WATER                                                                                                Time: 08:28:01  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                         0 PPM       SPECIAL       25 PPM       100 PPM      175 PPM                     
                                                                CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation, Chronic Active                                  1 (17%)                                1 (4%)                   
      Inflammation, Necrotizing                       24 (86%)      3 (50%)     13 (81%)     14 (78%)     15 (54%)                  
      Mineralization                                  11 (39%)                   7 (44%)      5 (28%)      4 (14%)                  
      Artery, Necrosis, Fibrinoid                                                             1 (6%)                                
   Pancreas                                           (100)        (42)         (60)         (59)         (98)                      
      Infiltration Cellular, Lymphocyte                                          1 (2%)                                             
      Inflammation, Chronic Active                     1 (1%)       1 (2%)       1 (2%)                                             
      Acinus, Atrophy                                  3 (3%)                                 4 (7%)       2 (2%)                   
      Acinus, Hyperplasia                                                                                  2 (2%)                   
      Duct, Ectasia                                                                           1 (2%)       3 (3%)                   
   Salivary Glands                                    (99)         (41)         (60)         (60)         (99)                      
      Duct, Ectasia                                                                                        1 (1%)                   
   Stomach, Forestomach                               (100)        (42)         (60)         (59)         (98)                      
      Acanthosis                                       5 (5%)                    6 (10%)      5 (8%)       3 (3%)                   
      Diverticulum                                     1 (1%)       1 (2%)       1 (2%)                                             
      Inflammation, Chronic Active                     3 (3%)       1 (2%)       5 (8%)       3 (5%)       5 (5%)                   
   Stomach, Glandular                                 (100)        (42)         (60)         (59)         (98)                      
      Cyst                                                                       1 (2%)                                             
      Erosion                                          1 (1%)       2 (5%)                                 3 (3%)                   
      Hyperplasia                                      2 (2%)                                                                       
      Inflammation, Chronic Active                                               1 (2%)                                             
      Mineralization                                                             1 (2%)                    4 (4%)                   
   Tooth                                              (90)         (42)         (60)         (60)         (89)                      
      Dentine, Incisor, Dysplasia                     34 (38%)      1 (2%)      21 (35%)     23 (38%)     24 (27%)                  
      Dentine, Incisor, Necrosis                                                              2 (3%)       2 (2%)                   
      Incisor, Lower, Dysplasia                                     1 (2%)                                                          
      Incisor, Ameloblast, Atrophy                     1 (1%)                                 1 (2%)       3 (3%)                   
      Incisor, Ameloblast, Degeneration                                                       1 (2%)                                
      Peridontal Tissue, Incisor, Inflammation,                                                                                     
           Suppurative                                                                        1 (2%)                                
      Peridontal Tissue, Incisor, Necrosis                                                                 1 (1%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (1)                                    (1)                                    
      Artery, Necrosis, Fibrinoid                                                             1 (100%)                              
   Heart                                              (99)         (41)         (60)         (60)         (99)                      
      Cardiomyopathy, Chronic                          1 (1%)                    1 (2%)       1 (2%)                                
      Inflammation, Chronic Active                     1 (1%)                                                                       
      Artery, Necrosis, Fibrinoid                                                             1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05131-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          SODIUM FLUORIDE                                      Date: 09/17/94  
Route: DOSED WATER                                                                                                Time: 08:28:01  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                         0 PPM       SPECIAL       25 PPM       100 PPM      175 PPM                     
                                                                CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (99)         (42)         (60)         (60)         (99)                      
      Accessory Adrenal Cortical Nodule                3 (3%)                                              1 (1%)                   
      Cyst                                                                                    1 (2%)       1 (1%)                   
      Cytoplasmic Alteration                                                                               1 (1%)                   
      Degeneration, Fatty                              2 (2%)                    3 (5%)       1 (2%)                                
      Fibrosis                                                                   1 (2%)                                             
      Hematopoietic Cell Proliferation                 1 (1%)                                 1 (2%)       2 (2%)                   
      Hyperplasia                                      3 (3%)       1 (2%)       1 (2%)                    2 (2%)                   
      Hypertrophy                                      6 (6%)                    1 (2%)       4 (7%)                                
      Capsule, Spindle Cell, Hyperplasia               1 (1%)                    1 (2%)       3 (5%)       1 (1%)                   
   Adrenal Gland, Medulla                             (96)         (42)         (60)         (60)         (98)                      
      Hyperplasia                                      1 (1%)                    1 (2%)                                             
      Hypertrophy                                      1 (1%)                                                                       
   Parathyroid Gland                                  (92)         (37)         (59)         (57)         (92)                      
      Cyst                                             1 (1%)                    1 (2%)                    1 (1%)                   
      Hyperplasia                                                   1 (3%)                                                          
   Pituitary Gland                                    (100)        (41)         (59)         (61)         (97)                      
      Craniopharyngeal Duct, Pars Distalis, Cyst                                              1 (2%)                                
      Craniopharyngeal Duct, Pars Distalis,                                                                                         
          Inflammation, Suppurative                                                           1 (2%)                                
      Pars Distalis, Cyst                              5 (5%)       1 (2%)                    4 (7%)       2 (2%)                   
      Pars Distalis, Hyperplasia                      16 (16%)      1 (2%)      20 (34%)     16 (26%)     25 (26%)                  
   Thyroid Gland                                      (100)        (42)         (60)         (60)         (99)                      
      Inflammation, Chronic Active                     1 (1%)       1 (2%)       1 (2%)       2 (3%)       2 (2%)                   
      Ultimobranchial Cyst                             1 (1%)                    1 (2%)       1 (2%)       3 (3%)                   
      Follicle, Cyst                                                                                       1 (1%)                   
      Follicular Cell, Hyperplasia                    30 (30%)      8 (19%)     27 (45%)     24 (40%)     33 (33%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (2)                       (2)                       (3)                       
      Pigmentation, Melanin                            1 (50%)                                                                      
      Duct, Dilatation                                 1 (50%)                   1 (50%)                                            
   Ovary                                              (98)         (41)         (57)         (58)         (98)                      
      Atrophy                                         63 (64%)     14 (34%)     38 (67%)     39 (67%)     59 (60%)                  
      Cyst                                            24 (24%)     12 (29%)     25 (44%)     16 (28%)     25 (26%)                  
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Mineralization                                   1 (1%)                    1 (2%)                                             
      Necrosis, Coagulative                                         1 (2%)                                 1 (1%)                   
      Thrombosis                                                                 2 (4%)                    1 (1%)                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05131-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          SODIUM FLUORIDE                                      Date: 09/17/94  
Route: DOSED WATER                                                                                                Time: 08:28:01  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                         0 PPM       SPECIAL       25 PPM       100 PPM      175 PPM                     
                                                                CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
   Uterus                                             (100)        (42)         (60)         (60)         (99)                      
      Angiectasis                                      1 (1%)                                              1 (1%)                   
      Dilatation                                      13 (13%)     11 (26%)     14 (23%)      6 (10%)     14 (14%)                  
      Hyperplasia, Cystic, Glandular                  81 (81%)     34 (81%)     54 (90%)     56 (93%)     81 (82%)                  
      Inflammation, Necrotizing                        1 (1%)                                                                       
      Inflammation, Suppurative                                                                            1 (1%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (100)        (42)         (62)         (61)         (99)                      
      Femoral, Hyperplasia, Mast Cell                  1 (1%)                                                                       
      Femoral, Myelofibrosis                          34 (34%)      5 (12%)     34 (55%)     34 (56%)     53 (54%)                  
      Humerus, Myelofibrosis                          28 (28%)      7 (17%)     27 (44%)     26 (43%)     47 (47%)                  
      Mandible, Myelofibrosis                          1 (1%)                                              1 (1%)                   
      Maxilla, Hyperplasia, Mast Cell                  1 (1%)                                                                       
      Maxilla, Myelofibrosis                          19 (19%)      3 (7%)      20 (32%)     21 (34%)     44 (44%)                  
      Thoracic, Vertebra, Myelofibrosis               61 (61%)     20 (48%)     50 (81%)     49 (80%)     74 (75%)                  
      Tibia, Myelofibrosis                            14 (14%)      3 (7%)      16 (26%)      9 (15%)     26 (26%)                  
   Lymph Node                                         (100)        (42)         (60)         (60)         (99)                      
      Mediastinal, Hyperplasia, Plasma Cell                         1 (2%)                                                          
      Renal, Sinus, Ectasia                                                                   1 (2%)                                
   Lymph Node, Mandibular                             (96)         (42)         (60)         (56)         (98)                      
      Hyperplasia, Lymphoid                                                                                2 (2%)                   
   Lymph Node, Mesenteric                             (99)         (40)         (57)         (57)         (94)                      
      Hyperplasia, Plasma Cell                         1 (1%)                                                                       
      Sinus, Ectasia                                   1 (1%)                    1 (2%)       1 (2%)                                
   Spleen                                             (99)         (42)         (60)         (59)         (99)                      
      Depletion Lymphoid                                                                      1 (2%)                                
      Fibrosis                                                                                1 (2%)                                
      Hematopoietic Cell Proliferation                20 (20%)     10 (24%)     15 (25%)     15 (25%)     20 (20%)                  
      Hemorrhage                                                                                           1 (1%)                   
      Hyperplasia, Lymphoid                           10 (10%)      3 (7%)       7 (12%)      7 (12%)     11 (11%)                  
   Thymus                                             (96)         (42)         (56)         (55)         (92)                      
      Cyst                                             4 (4%)       3 (7%)       6 (11%)      4 (7%)       6 (7%)                   
      Ectopic Parathyroid Gland                                     1 (2%)                                                          
      Hyperplasia, Lymphoid                                                      3 (5%)                    2 (2%)                   
      Artery, Necrosis, Fibrinoid                                                             1 (2%)                                
      Thymocyte, Necrosis                                           1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (98)         (41)         (59)         (60)         (99)                      
      Hyperplasia, Cystic                              8 (8%)       7 (17%)      8 (14%)      8 (13%)      7 (7%)                   
      Inflammation, Chronic Active                                  1 (2%)                                                          
   Skin                                               (100)        (42)         (60)         (60)         (99)                      
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05131-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          SODIUM FLUORIDE                                      Date: 09/17/94  
Route: DOSED WATER                                                                                                Time: 08:28:01  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                         0 PPM       SPECIAL       25 PPM       100 PPM      175 PPM                     
                                                                CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
      Acanthosis                                       1 (1%)                                                                       
      Alopecia                                                                                1 (2%)                                
      Cyst Epithelial Inclusion                                                  1 (2%)                                             
      Hyperkeratosis                                   1 (1%)                                                                       
      Inflammation, Chronic Active                     2 (2%)                    2 (3%)       1 (2%)       2 (2%)                   
      Mineralization                                   1 (1%)                                                                       
      Artery, Necrosis, Fibrinoid                                                             1 (2%)                                
      Hair Follicle, Cyst                              1 (1%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (90)         (42)         (60)         (60)         (89)                      
      Femur, Osteosclerosis                                                                                1 (1%)                   
      Humerus, Osteosclerosis                          2 (2%)                                              2 (2%)                   
      Humerus, Periosteum, Proliferation, Focal                                  1 (2%)                                             
      Intervertebral Disc, Degeneration               14 (16%)      2 (5%)      13 (22%)      8 (13%)     16 (18%)                  
      Mandible, Inflammation, Suppurative                           1 (2%)                                                          
      Periosteum, Tibia, Proliferation, Focal          1 (1%)                                                                       
      Periosteum, Maxilla, Proliferation, Focal                                  1 (2%)                                             
      Rib, Cartilage, Degeneration                                               1 (2%)       1 (2%)       1 (1%)                   
      Rib, Cartilage, Necrosis                         1 (1%)                                                                       
      Thoracic, Vertebra, Osteosclerosis               1 (1%)                    1 (2%)                    3 (3%)                   
      Tibia, Osteosclerosis                                         1 (2%)                                 2 (2%)                   
   Skeletal Muscle                                    (12)         (1)                       (1)          (11)                      
      Inflammation, Chronic Active                                  1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (100)        (42)         (60)         (60)         (99)                      
      Compression                                      3 (3%)                    2 (3%)       2 (3%)       1 (1%)                   
      Hydrocephalus                                    3 (3%)                    1 (2%)       1 (2%)                                
      Inflammation, Chronic Active                                                                         1 (1%)                   
      Artery, Necrosis, Fibrinoid                                                             1 (2%)                                
      Neuron, Necrosis                                                           1 (2%)                                             
      White Matter, Degeneration                                                 1 (2%)                                             
   Peripheral Nerve                                   (1)                       (1)          (3)          (1)                       
      Sciatic, Degeneration                                                      1 (100%)     1 (33%)                               
      Spinal, Degeneration                                                                    1 (33%)                               
   Spinal Cord                                        (1)                       (1)          (3)          (1)                       
      White Matter, Degeneration                                                              1 (33%)      1 (100%)                 
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05131-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          SODIUM FLUORIDE                                      Date: 09/17/94  
Route: DOSED WATER                                                                                                Time: 08:28:01  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                         0 PPM       SPECIAL       25 PPM       100 PPM      175 PPM                     
                                                                CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (100)        (42)         (60)         (60)         (99)                      
      Inflammation, Chronic Active                     3 (3%)       1 (2%)       4 (7%)       1 (2%)       3 (3%)                   
      Leukocytosis                                                  2 (5%)                    1 (2%)                                
      Mineralization                                                             1 (2%)       1 (2%)                                
      Pigmentation, Hemosiderin                                                  1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 2 (2%)       2 (5%)       3 (5%)       1 (2%)                                
   Nose                                               (100)        (42)         (60)         (60)         (99)                      
      Inflammation, Chronic Active                                  1 (2%)                    1 (2%)                                
      Nasolacrimal Duct, Inflammation, Suppurative     1 (1%)                    1 (2%)       3 (5%)       1 (1%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                                          (1)          (1)          (1)                       
      Middle Ear, Inflammation, Suppurative                                                   1 (100%)                              
   Eye                                                (1)          (1)          (2)          (3)          (1)                       
      Inflammation, Chronic Active                     1 (100%)                                                                     
      Phthisis Bulbi                                                             1 (50%)                                            
      Cornea, Inflammation, Chronic Active                                                    2 (67%)                               
      Lens, Cataract                                                             1 (50%)                                            
      Retina, Atrophy                                                            1 (50%)                                            
   Harderian Gland                                    (66)         (36)         (48)         (45)         (52)                      
      Hyperplasia                                                   1 (3%)       2 (4%)                                             
      Inflammation, Chronic Active                                  1 (3%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (100)        (42)         (60)         (60)         (99)                      
      Atypia Cellular                                                                                      1 (1%)                   
      Cyst                                                          1 (2%)       2 (3%)                    1 (1%)                   
      Hydronephrosis                                   1 (1%)                                 1 (2%)                                
      Hypertrophy                                      1 (1%)                                                                       
      Metaplasia, Osseous                                                        1 (2%)       1 (2%)       1 (1%)                   
      Mineralization                                  63 (63%)     22 (52%)     34 (57%)     26 (43%)     28 (28%)                  
      Necrosis, Coagulative                                         1 (2%)                                                          
      Nephropathy, Chronic                            52 (52%)     12 (29%)     43 (72%)     29 (48%)     26 (26%)                  
      Artery, Necrosis, Fibrinoid                                                             1 (2%)                                
      Perivascular, Hyperplasia, Lymphoid                                                                  2 (2%)                   
      Renal Tubule, Necrosis                                                                               3 (3%)                   
   Urinary Bladder                                    (100)        (42)         (60)         (60)         (97)                      
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05131-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          SODIUM FLUORIDE                                      Date: 09/17/94  
Route: DOSED WATER                                                                                                Time: 08:28:01  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                         0 PPM       SPECIAL       25 PPM       100 PPM      175 PPM                     
                                                                CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Inflammation, Necrotizing                        1 (1%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05131-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          SODIUM FLUORIDE                                      Date: 09/17/94  
Route: DOSED WATER                                                                                                Time: 08:28:01  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                           0 PPM       SPECIAL       25 PPM       100 PPM      175 PPM                     
                                                                CONTROL                                                             
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          99           50           70           70          100                        
  Scheduled Sacrifice                                 20                        20           19           20                        
  Early Deaths                                                                                                                      
    Natural Death                                     16            3            8            6           11                        
    Moribund Sacrifice                                 5            9            3            8            4                        
  Survivors                                                                                                                         
    Natural Death                                      2                                                                            
    Terminal Sacrifice                                56           18           39           37           65                        
  Special Control                                                  20                                                               
  Animals Examined Microscopically                    99           32           60           62          100                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (96)         (32)         (58)         (59)         (100)                     
      Cyst                                                          1 (3%)                                                          
   Intestine Small, Duodenum                          (99)         (32)         (60)         (59)         (100)                     
      Erosion                                                                    1 (2%)                                             
      Intussusception                                                                         1 (2%)                                
   Intestine Small, Jejunum                           (99)         (32)         (60)         (59)         (100)                     
      Lymphoid Tissue, Hyperplasia                                               2 (3%)       1 (2%)                                
      Peyer's Patch, Hyperplasia, Lymphoid                                       2 (3%)                                             
   Liver                                              (99)         (32)         (60)         (61)         (100)                     
      Basophilic Focus                                 9 (9%)       1 (3%)       6 (10%)      2 (3%)       5 (5%)                   
      Clear Cell Focus                                36 (36%)      7 (22%)     27 (45%)     31 (51%)     48 (48%)                  
      Clear Cell Focus, Multiple                                    1 (3%)                                                          
      Cytologic Alterations                            1 (1%)                    1 (2%)                                             
      Eosinophilic Focus                               9 (9%)       2 (6%)       9 (15%)     12 (20%)      6 (6%)                   
      Fibrosis                                                                   1 (2%)                                             
      Hyperplasia                                      1 (1%)                    2 (3%)                                             
      Inflammation, Chronic Active                     2 (2%)       2 (6%)       7 (12%)      1 (2%)                                
      Mineralization                                                             1 (2%)                    1 (1%)                   
      Mixed Cell Focus                                                                        1 (2%)       2 (2%)                   
      Necrosis, Coagulative                            4 (4%)       3 (9%)       5 (8%)       4 (7%)       4 (4%)                   
      Vacuolization Cytoplasmic                       24 (24%)     13 (41%)     18 (30%)     17 (28%)     27 (27%)                  
      Bile Duct, Cyst                                                                         1 (2%)                                
      Bile Duct, Hyperplasia                                                     1 (2%)                                             
   Mesentery                                          (10)         (2)          (5)          (8)          (4)                       
      Inflammation, Chronic Active                                                            1 (13%)      1 (25%)                  
      Inflammation, Necrotizing                        8 (80%)      1 (50%)      4 (80%)      6 (75%)      2 (50%)                  
      Mineralization                                   1 (10%)                   2 (40%)      2 (25%)      1 (25%)                  
   Pancreas                                           (98)         (32)         (60)         (60)         (100)                     
      Inflammation, Chronic Active                     1 (1%)                                                                       
      Acinus, Amyloid Deposition                                                              1 (2%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05131-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          SODIUM FLUORIDE                                      Date: 09/17/94  
Route: DOSED WATER                                                                                                Time: 08:28:01  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                           0 PPM       SPECIAL       25 PPM       100 PPM      175 PPM                     
                                                                CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Acinus, Atrophy                                  3 (3%)                    1 (2%)       1 (2%)       1 (1%)                   
      Acinus, Inflammation, Chronic Active             1 (1%)                    1 (2%)                                             
      Acinus, Necrosis, Coagulative                                              1 (2%)                                             
   Stomach, Forestomach                               (99)         (32)         (60)         (60)         (99)                      
      Acanthosis                                       2 (2%)                    1 (2%)       1 (2%)                                
      Cyst Epithelial Inclusion                                                               1 (2%)       1 (1%)                   
      Diverticulum                                                  1 (3%)                    1 (2%)       2 (2%)                   
      Inflammation, Chronic Active                     1 (1%)                    1 (2%)       1 (2%)                                
      Mineralization                                                1 (3%)                                                          
   Stomach, Glandular                                 (99)         (32)         (60)         (60)         (100)                     
      Erosion                                          1 (1%)                    1 (2%)       1 (2%)       2 (2%)                   
      Inflammation, Chronic Active                     1 (1%)                                                                       
      Mineralization                                   2 (2%)                    2 (3%)       1 (2%)       4 (4%)                   
      Perivascular, Inflammation, Chronic Active                                              1 (2%)                                
   Tooth                                              (90)         (32)         (60)         (60)         (90)                      
      Dentine, Incisor, Concretion                                                                         1 (1%)                   
      Dentine, Incisor, Degeneration                                             1 (2%)                                             
      Dentine, Incisor, Dysplasia                     69 (77%)     17 (53%)     52 (87%)     48 (80%)     82 (91%)                  
      Dentine, Incisor, Necrosis                       2 (2%)                                              2 (2%)                   
      Gingiva, Incisor, Inflammation, Suppurative                                1 (2%)                                             
      Incisor, Lower, Dysplasia                        8 (9%)       6 (19%)     14 (23%)     17 (28%)     14 (16%)                  
      Incisor, Ameloblast, Atrophy                    42 (47%)     15 (47%)     29 (48%)     27 (45%)     50 (56%)                  
      Peridontal Tissue, Incisor, Inflammation,                                                                                     
           Suppurative                                                           1 (2%)                    1 (1%)                   
      Pulp, Incisor, Inflammation, Suppurative                                                1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (3)                       (1)          (1)          (2)                       
      Inflammation, Chronic Active                                               1 (100%)                                           
      Aorta, Inflammation, Chronic Active                                                     1 (100%)     1 (50%)                  
      Mesenteric Artery, Inflammation, Chronic                                                                                      
          Active                                       1 (33%)                                1 (100%)                              
      Mesenteric Artery, Necrosis, Fibrinoid           1 (33%)                                                                      
      Renal Artery, Inflammation, Chronic Active       1 (33%)                                                                      
      Thoracic, Artery, Inflammation, Chronic                                                                                       
          Active                                                                              1 (100%)                              
   Heart                                              (99)         (32)         (60)         (59)         (100)                     
      Cardiomyopathy, Chronic                          2 (2%)                    1 (2%)                    1 (1%)                   
      Mineralization                                                2 (6%)                                                          
      Perivascular, Inflammation, Chronic Active                                              1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05131-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          SODIUM FLUORIDE                                      Date: 09/17/94  
Route: DOSED WATER                                                                                                Time: 08:28:01  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                           0 PPM       SPECIAL       25 PPM       100 PPM      175 PPM                     
                                                                CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (99)         (32)         (60)         (60)         (100)                     
      Accessory Adrenal Cortical Nodule                2 (2%)                    1 (2%)                    1 (1%)                   
      Atrophy                                                                    1 (2%)                                             
      Cyst                                             2 (2%)                    2 (3%)       1 (2%)                                
      Hyperplasia                                      3 (3%)       1 (3%)       1 (2%)       4 (7%)       7 (7%)                   
      Hypertrophy                                     34 (34%)      7 (22%)     16 (27%)     23 (38%)     32 (32%)                  
      Bilateral, Capsule, Spindle Cell, Hyperplasia    1 (1%)       1 (3%)                    1 (2%)       2 (2%)                   
      Capsule, Spindle Cell, Hyperplasia              11 (11%)      1 (3%)       8 (13%)     10 (17%)     13 (13%)                  
   Adrenal Gland, Medulla                             (96)         (32)         (60)         (60)         (99)                      
      Hyperplasia                                                                1 (2%)       1 (2%)       1 (1%)                   
   Islets, Pancreatic                                 (98)         (32)         (60)         (60)         (100)                     
      Hyperplasia                                     13 (13%)      7 (22%)      7 (12%)     17 (28%)     15 (15%)                  
   Parathyroid Gland                                  (88)         (30)         (55)         (55)         (97)                      
      Cyst                                             2 (2%)                    1 (2%)                                             
   Pituitary Gland                                    (91)         (32)         (59)         (57)         (93)                      
      Pars Distalis, Cyst                              2 (2%)                    6 (10%)      5 (9%)       4 (4%)                   
      Pars Distalis, Hyperplasia                       3 (3%)                    1 (2%)       2 (4%)                                
      Pars Intermedia, Cyst                                                      1 (2%)                                             
   Thyroid Gland                                      (99)         (32)         (60)         (60)         (100)                     
      Cyst                                             1 (1%)                                                                       
      Inflammation, Chronic Active                     1 (1%)                    1 (2%)       1 (2%)       1 (1%)                   
      Ultimobranchial Cyst                                          1 (3%)                    2 (3%)       1 (1%)                   
      Follicle, Cyst                                                                                       1 (1%)                   
      Follicular Cell, Hyperplasia                     6 (6%)       1 (3%)      10 (17%)      6 (10%)     12 (12%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (99)         (32)         (60)         (60)         (99)                      
      Aspermia                                         1 (1%)                                              2 (2%)                   
      Atrophy                                                                                              2 (2%)                   
      Granuloma Sperm                                  2 (2%)                    2 (3%)                    4 (4%)                   
      Inflammation, Chronic Active                     2 (2%)       1 (3%)                    1 (2%)       1 (1%)                   
      Mineralization                                                             1 (2%)       2 (3%)                                
      Duct, Dilatation                                 1 (1%)                                                                       
   Preputial Gland                                    (57)         (12)         (40)         (33)         (55)                      
      Atrophy                                         48 (84%)     11 (92%)     30 (75%)     27 (82%)     35 (64%)                  
      Inflammation, Chronic Active                    22 (39%)      5 (42%)     18 (45%)     14 (42%)     25 (45%)                  
      Duct, Dilatation                                51 (89%)     11 (92%)     36 (90%)     32 (97%)     47 (85%)                  
   Prostate                                           (99)         (32)         (60)         (60)         (99)                      
      Atrophy                                                                                              2 (2%)                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05131-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          SODIUM FLUORIDE                                      Date: 09/17/94  
Route: DOSED WATER                                                                                                Time: 08:28:01  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                           0 PPM       SPECIAL       25 PPM       100 PPM      175 PPM                     
                                                                CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Inflammation, Chronic Active                     3 (3%)       1 (3%)       1 (2%)                    1 (1%)                   
   Seminal Vesicle                                    (99)         (32)         (60)         (60)         (100)                     
      Cyst                                                                       1 (2%)       1 (2%)                                
      Inflammation, Chronic Active                     2 (2%)       1 (3%)       2 (3%)       1 (2%)       1 (1%)                   
   Testes                                             (98)         (31)         (60)         (60)         (99)                      
      Mineralization                                                1 (3%)                    2 (3%)                                
      Necrosis, Coagulative                                                                   1 (2%)                                
      Seminiferous Tubule, Atrophy                                                                         2 (2%)                   
      Seminiferous Tubule, Degeneration                                          2 (3%)                    3 (3%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (99)         (32)         (60)         (60)         (100)                     
      Femoral, Myelofibrosis                           1 (1%)                    1 (2%)       5 (8%)       2 (2%)                   
      Femoral, Necrosis, Coagulative                                                                       1 (1%)                   
      Humerus, Myelofibrosis                                                     1 (2%)       2 (3%)                                
      Maxilla, Myelofibrosis                           1 (1%)                    2 (3%)                                             
      Thoracic, Vertebra, Myelofibrosis                                                                    1 (1%)                   
      Tibia, Myelofibrosis                                                                    1 (2%)                                
   Lymph Node                                         (99)         (32)         (60)         (60)         (100)                     
      Inguinal, Hyperplasia, Plasma Cell                                                                   1 (1%)                   
      Renal, Sinus, Ectasia                                                      1 (2%)                                             
   Lymph Node, Mandibular                             (98)         (31)         (60)         (59)         (100)                     
      Hyperplasia, Plasma Cell                                                                2 (3%)                                
   Lymph Node, Mesenteric                             (94)         (31)         (59)         (56)         (92)                      
      Hematopoietic Cell Proliferation                                                        1 (2%)                                
      Hyperplasia, Lymphoid                                                      4 (7%)                                             
      Inflammation, Chronic Active                                                                         1 (1%)                   
      Thrombosis                                                                 1 (2%)                                             
   Spleen                                             (99)         (32)         (60)         (60)         (100)                     
      Atrophy                                                                                 1 (2%)       2 (2%)                   
      Hematopoietic Cell Proliferation                 8 (8%)       3 (9%)      10 (17%)      7 (12%)      9 (9%)                   
      Hyperplasia, Lymphoid                            1 (1%)                                                                       
   Thymus                                             (87)         (28)         (52)         (45)         (85)                      
      Atrophy                                                                    2 (4%)                                             
      Cyst                                            11 (13%)      3 (11%)     13 (25%)      6 (13%)     11 (13%)                  
      Hyperplasia, Lymphoid                                                                                1 (1%)                   
      Inflammation, Chronic Active                     1 (1%)                                                                       
      Thymocyte, Necrosis                                                                                  1 (1%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05131-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          SODIUM FLUORIDE                                      Date: 09/17/94  
Route: DOSED WATER                                                                                                Time: 08:28:01  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                           0 PPM       SPECIAL       25 PPM       100 PPM      175 PPM                     
                                                                CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (99)         (31)         (60)         (60)         (100)                     
      Autolysis                                        1 (1%)                                                                       
      Inflammation, Chronic Active                     2 (2%)                                              1 (1%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (89)         (32)         (60)         (60)         (90)                      
      Calvarium, Hyperostosis                                                                              1 (1%)                   
      Calvarium, Osteosclerosis, Focal                                                        1 (2%)                                
      Humerus, Osteosclerosis                                                    1 (2%)                                             
      Humerus, Joint, Cartilage, Hyperplasia, Focal                                                        1 (1%)                   
      Intervertebral Disc, Degeneration                6 (7%)       2 (6%)      10 (17%)      6 (10%)      8 (9%)                   
      Joint, Cartilage, Tibia, Degeneration                                                                2 (2%)                   
      Rib, Cartilage, Degeneration                                                            1 (2%)       2 (2%)                   
      Thoracic, Vertebra, Osteosclerosis               2 (2%)       1 (3%)                                 3 (3%)                   
      Tibia, Fracture Healed                                        1 (3%)                                                          
      Tibia, Osteosclerosis                                                                                1 (1%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (99)         (32)         (60)         (60)         (100)                     
      Infiltration Cellular, Lymphocyte                                          1 (2%)                                             
      Infiltration Cellular, Histiocyte                                                                    1 (1%)                   
      Inflammation, Chronic Active                     4 (4%)                    2 (3%)       2 (3%)       4 (4%)                   
      Leukocytosis                                     1 (1%)       1 (3%)                                 1 (1%)                   
      Mineralization                                                                                       1 (1%)                   
      Pigmentation, Hemosiderin                        1 (1%)                                                                       
      Thrombosis                                                                                           1 (1%)                   
      Alveolar Epithelium, Hyperplasia                 4 (4%)                    4 (7%)       4 (7%)       3 (3%)                   
      Bronchus, Dilatation                                                       1 (2%)                                             
      Mediastinum, Mineralization                      1 (1%)                                                                       
   Nose                                               (99)         (32)         (60)         (60)         (100)                     
      Inflammation, Chronic Active                     1 (1%)       1 (3%)                                 2 (2%)                   
      Nasolacrimal Duct, Hyperplasia, Squamous         1 (1%)                                                                       
      Nasolacrimal Duct, Inflammation, Suppurative     7 (7%)                    5 (8%)       2 (3%)       2 (2%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
NTP Experiment-Test: 05131-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          SODIUM FLUORIDE                                      Date: 09/17/94  
Route: DOSED WATER                                                                                                Time: 08:28:01  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                           0 PPM       SPECIAL       25 PPM       100 PPM      175 PPM                     
                                                                CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                (1)          (1)                       (2)          (1)                       
      Middle Ear, Inflammation, Suppurative                                                   1 (50%)                               
   Eye                                                (5)                                                                           
      Phthisis Bulbi                                   1 (20%)                                                                      
      Cornea, Inflammation, Chronic Active             2 (40%)                                                                      
      Cornea, Mineralization                           1 (20%)                                                                      
      Lens, Cataract                                   2 (40%)                                                                      
      Retina, Atrophy                                  1 (20%)                                                                      
   Harderian Gland                                    (85)         (27)         (49)         (52)         (75)                      
      Hyperplasia                                                                1 (2%)                                             
      Inflammation, Chronic Active                                                            2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (99)         (32)         (60)         (60)         (100)                     
      Cyst                                            17 (17%)      4 (13%)     10 (17%)     13 (22%)     11 (11%)                  
      Hydronephrosis                                                2 (6%)       1 (2%)                                             
      Inflammation, Chronic Active                     2 (2%)       1 (3%)       2 (3%)                    1 (1%)                   
      Inflammation, Necrotizing                                                               1 (2%)                                
      Metaplasia, Osseous                                                                     1 (2%)                                
      Mineralization                                  75 (76%)     28 (88%)     47 (78%)     44 (73%)     73 (73%)                  
      Necrosis, Coagulative                            1 (1%)                                              1 (1%)                   
      Nephropathy, Chronic                            76 (77%)     27 (84%)     56 (93%)     53 (88%)     78 (78%)                  
      Artery, Necrosis, Fibrinoid                      1 (1%)                                                                       
      Pelvis, Bacterium                                                                                    1 (1%)                   
      Renal Tubule, Epithelium, Hyperplasia                                                   1 (2%)                                
   Urinary Bladder                                    (98)         (32)         (60)         (59)         (100)                     
      Calculus Gross Observation                                                 1 (2%)                                             
      Calculus Micro Observation Only                                                         1 (2%)                                
      Inflammation, Chronic Active                     2 (2%)                                 1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   14                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------                                           

--multipart-boundary
Content-type: text/plain
Range: bytes 89857-89857/89857


--multipart-boundary--